Toni L. Pitcher

66 Stewart St
Christchurch, CAN 8011, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Thalamic nuclei insights into Alzheimer's disease.

Thalamic nuclei insights into Alzheimer's disease.

Journal: bioRxiv : the preprint server for biology

Published: June 05, 2026

Author Response: Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease.

Author Response: Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease.

Journal: Neurology

Published: February 17, 2025

Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson's disease.

Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson's disease.

Journal: Brain communications

Published: October 21, 2024

Clinical features and mortality outcomes of people transferred from prison to forensic mental health units: a nationwide 14-year retrospective cohort study.

Clinical features and mortality outcomes of people transferred from prison to forensic mental health units: a nationwide 14-year retrospective cohort study.

Journal: Social psychiatry and psychiatric epidemiology

Published: September 25, 2024

Higher Frequency of Stuttered Disfluencies Negatively Affects Communicative Participation in Parkinson's Disease.

Higher Frequency of Stuttered Disfluencies Negatively Affects Communicative Participation in Parkinson's Disease.

Journal: Journal of speech, language, and hearing research : JSLHR

Published: September 12, 2024

Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease.

Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease.

Journal: Neurology

Published: June 03, 2024

A worldwide study of subcortical shape as a marker for clinical staging in Parkinson's disease.

A worldwide study of subcortical shape as a marker for clinical staging in Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: May 13, 2024

A worldwide study of white matter microstructural alterations in people living with Parkinson's disease.

A worldwide study of white matter microstructural alterations in people living with Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: January 17, 2024

Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.

Early-phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: November 16, 2023

Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA-PD Study.

Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA-PD Study.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: May 29, 2023

Cyclic Glycine-Proline (cGP) Normalises Insulin-Like Growth Factor-1 (IGF-1) Function: Clinical Significance in the Ageing Brain and in Age-Related Neurological Conditions.

Cyclic Glycine-Proline (cGP) Normalises Insulin-Like Growth Factor-1 (IGF-1) Function: Clinical Significance in the Ageing Brain and in Age-Related Neurological Conditions.

Journal: Molecules (Basel, Switzerland)

Published: November 14, 2022

The New Zealand Parkinson's progression programme.

The New Zealand Parkinson's progression programme.

Journal: Journal of the Royal Society of New Zealand

Published: August 14, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026